Olagunju Peter 4
4 · TCR2 THERAPEUTICS INC. · Filed Nov 18, 2022
Insider Transaction Report
Form 4
Olagunju Peter
Chief Technical Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2022-11-17−254,847→ 0 totalExercise: $12.69Exp: 2031-07-25→ Common Stock (254,847 underlying) - Disposition to Issuer
Stock Option (right to buy)
2022-11-17−31,520→ 0 totalExercise: $12.69Exp: 2031-07-25→ Common Stock (31,520 underlying) - Award
Restricted Stock Unit (right to buy)
2022-11-17+84,949→ 84,949 total→ Common Stock (84,949 underlying) - Award
Restricted Stock Unit (right to buy)
2022-11-17+10,507→ 10,507 total→ Common Stock (10,507 underlying)
Holdings
- 2,192
Common Stock
Footnotes (5)
- [F1]This cancelled option vested 25% on July 26, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
- [F2]On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 10,507.
- [F3]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
- [F4]35% of these RSUs will vest December 1, 2022, 25% of these RSUs will vest on each of December 1, 2023 and December 1, 2024, and the remaining 15% of RSUs will vest on December 1, 2025.
- [F5]On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 84,949.